Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia
Contributeurs/tricesRoesch-Ely, D; Göhring, K; Gruschka, P; Kaiser, Stefan; Pfüller, U; Burlon, M; Weisbrod, M
Publié dansPharmacopsychiatry, vol. 39, no. 3, p. 115-116
Date de publication2006
Résumé
Mots-clés
- Adult
- Antipsychotic Agents/administration & dosage
- Comorbidity
- Depressive Disorder/diagnosis/drug therapy/psychology
- Dopamine Agonists/administration & dosage
- Drug Therapy, Combination
- Frontal Lobe/drug effects
- Hallucinations/diagnosis/drug therapy/psychology
- Humans
- Male
- Neural Pathways/drug effects
- Pergolide/administration & dosage
- Psychiatric Status Rating Scales
- Receptors, Dopamine D1/agonists
- Receptors, Dopamine D2/agonists
- Schizophrenia, Paranoid/diagnosis/drug therapy/psychology
- Sulpiride/administration & dosage/analogs & derivatives
- Treatment Outcome
Structure d'affiliation Pas une publication de l'UNIGE
Citation (format ISO)
ROESCH-ELY, D et al. Pergolide as adjuvant therapy to amisulpride in the treatment of negative and depressive symptoms in schizophrenia. In: Pharmacopsychiatry, 2006, vol. 39, n° 3, p. 115–116. doi: 10.1055/s-2006-941488
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:100588
- DOI : 10.1055/s-2006-941488
- PMID : 16721703
ISSN du journal0176-3679